Prognostic Factors and Novel Therapy in Urothelial Cancer

  • 10k

    Total downloads

  • 30k

    Total views and downloads

Articles

CASE REPORT

Published on 04 Mar 2021

Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction

  • Paul V. Viscuse
  • Mario L. Marques-Piubelli
  • Meghan M. Heberton
  • Edwin Roger Parra
  • Amishi Y. Shah
  • Arlene Siefker-Radtke
  • Jianjun Gao
  • Sangeeta Goswami
  • Doina Ivan
  • 1 more
  • Matthew T. Campbell
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction
doi 10.3389/fonc.2021.621591
  • 8,046 views
  • 39 citations

Impact

  • 30kTopic views
  • 18kArticle views
  • 10kArticle downloads
View impact